Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Construction in Progress: 2013-2014

Historic Construction in Progress for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Dec 2014 value amounting to $25.1 million.

  • Amphastar Pharmaceuticals' Construction in Progress rose 49.01% to $29.5 million in Q2 2015 from the same period last year, while for Jun 2015 it was $29.5 million, marking a year-over-year increase of 49.01%. This contributed to the annual value of $25.1 million for FY2014, which is 59.82% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Construction in Progress stood at $25.1 million for FY2014, which was up 59.82% from $15.7 million recorded in FY2013.
  • In the past 5 years, Amphastar Pharmaceuticals' Construction in Progress registered a high of $25.1 million during FY2014, and its lowest value of $15.7 million during FY2013.
  • For the 2-year period, Amphastar Pharmaceuticals' Construction in Progress averaged around $20.4 million, with its median value being $20.4 million (2013).
  • Data for Amphastar Pharmaceuticals' Construction in Progress shows a peak YoY surged of 59.82% (in 2014) over the last 5 years.
  • Over the past 2 years, Amphastar Pharmaceuticals' Construction in Progress (Yearly) stood at $15.7 million in 2013, then skyrocketed by 59.82% to $25.1 million in 2014.